Ameren Short Interest Climbs to Year High Before Q3 Report
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
AEE short interest has risen 20% over the past month to 5.8% of the free float, the highest level in at least a year, setting an unusual tone ahead of Q3 results due November 5.
The climb in short positions is the most notable feature of the current setup. From roughly 12 million shares shorted at the start of October, the total has jumped to 15.6 million, with most of the increase arriving in the two weeks before the print. Days to cover now stand at 7.3, based on the latest FINRA fortnightly figure. Against that, borrow conditions remain comfortable: availability is over 1,000%, meaning there are ten shares available to borrow for every one already lent out, and the cost to borrow at 0.47% is negligible. The short side is building, but it is not yet squeezed or expensive to maintain. Options positioning reinforces the non-bearish read. The put/call ratio of 0.27 is more than one standard deviation below its 20-day average of 0.36, pointing to unusually call-heavy positioning for an earnings week, inconsistent with a market bracing for a bad number.
Analyst opinion heading into the report has tilted cautious, with several firms cutting targets in October even as they kept positive ratings. Barclays lowered its target to $109 from $117 on October 19 while holding Equal-Weight, and Morgan Stanley followed two days later with a $1 lift to $109, also Equal-Weight. BMO cut from $119 to $113. The mean target across the Street is $115, roughly 4% above the current price of $110.54. That gap is narrow for a utility trading at 19x earnings, and the price/book multiple has expanded by around 0.17 turns over the past 30 days, so the stock has re-rated even as several analysts trimmed. The bull case centres on a 3% retail sales increase at Ameren Missouri and a positive earnings trajectory from rate relief. The bear case focuses on dilution from roughly 5.8 million shares to be issued under forward sale agreements, combined with weather normalisation weighing on volumes in the quarters ahead.
AEE gained 2.3% over the past week, modestly behind the median of its closest peers. WEC rose 4.5% and CNP 3.3% over the same period, while CMS and ED were closer to flat. The underperformance relative to WEC and CNP is not dramatic, but it suggests the stock has not fully participated in the utility sector's recent bid. T. Rowe Price remains the largest institutional holder with 11.8% of shares, and added nearly 3.9 million shares as of September 30, one of the larger active additions in the register.
The Q3 print will test whether the rate relief contribution and sales volume growth are materialising at a pace that justifies a stock trading near the top of analyst target ranges, at a moment when short interest is at its highest point in over a year.
Stocks in this article
See the live data behind this article on ORTEX.
Open AEE on ORTEX →How this article was generated
- Generated
- 2 Nov 2026, 04:07
- Data as of
- 2 Nov 2026, 04:00
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.